简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-11-04 16:50 Newly Established Samsung Epis Holdings to Drive Growth for Samsung Bioepis and a New Subsidiary
2025-11-04 10:09 New Phase 3 Data Show Takeda’s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization
2025-10-31 14:45 IFF Honors Distinguished Academics Shaping the Future of Nutrition, Health and Biosciences
2025-10-31 12:36 Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory
2025-10-31 11:38 Novotech Maps Global Growth in Radiopharmaceutical Trials
2025-10-30 15:14 Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year
2025-10-30 10:25 Swiss Rockets Announces Strategic Exclusive License Acquisition of Cutting-Edge Sequencing Technology from MGI Tech and Complete Genomics
2025-10-30 10:23 Ferring Pharmaceuticals to Explore Strategic Options for Rebyota®
2025-10-28 15:03 Pacific Prime Released State of Health Insurance Report 2025
2025-10-28 10:27 Colorectal, Liver, and Lung Cancer Patients at Vinmec Experience Extended Survival with AIET Cell-Based Immunotherapy – Technology Transferred from Japan
2025-10-27 15:16 Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital
2025-10-27 13:39 SINOVAC Announces Appointment of Independent Auditor
2025-10-27 12:30 Berry Consultants Releases FACTS 8 Clinical Trial Simulator
2025-10-24 10:51 AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for "Bubble Baby Disease"
2025-10-23 13:56 Galderma Delivers Record Net Sales of 3.737 Billion USD in the First Nine Months of 2025 and 15.0% Year-on-Year Growth at Constant Currency, Raises Full-Year Guidance
2025-10-23 11:35 Hologic to be Acquired by Blackstone and TPG for up to $79 per Share
2025-10-23 11:19 HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members
2025-10-22 14:03 Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors
2025-10-22 13:58 Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule
2025-10-22 12:43 BeOne Medicines Presents New Data on TEVIMBRA in Lung Cancer at ESMO 2025